Airway hyper-responsiveness in lipopolysaccharide-challenged common marmosets (Callithrix jacchus)
Autor: | Armin Braun, Tamara Becker, Christoph Curths, Horst Windt, Heinz-Gerd Hoymann, Judy Wichmann, Hans D Lauenstein, Franz-Josef Kaup, Jens M. Hohlfeld, Sascha Knauf, S Dunker |
---|---|
Přispěvatelé: | Publica |
Jazyk: | angličtina |
Rok vydání: | 2014 |
Předmět: |
Lipopolysaccharides
Male VT tidal volume Airway resistance RL lung resistance Lung-function measurement EF50 mid-expiratory flow Tidal volume Methacholine Chloride biology NHP non-human primate Marmoset Callithrix General Medicine Lung resistance respiratory system AHR airway hyper-responsiveness Respiratory Function Tests Plethysmography medicine.anatomical_structure CRP C-reactive protein LPS lipopolysaccharide Bronchoconstriction Female medicine.symptom Bronchial Hyperreactivity Cdyn dynamic compliance medicine.drug Airway hyper-responsiveness Lipopolysaccharide S8 biology.animal medicine Animals PTP transpulmonary pressure Original Paper Lung business.industry biology.organism_classification MCh methacholine Non-human primate PD provocative dose Poes oesophageal pressure COPD chronic obstructive pulmonary disease Immunology Methacholine business Respiratory minute volume MV minute volume |
Zdroj: | Clinical Science (London, England : 1979) |
Popis: | Animal models with a high predictive value for human trials are needed to develop novel human-specific therapeutics for respiratory diseases. The aim of the present study was to examine lung-function parameters in marmoset monkeys (Callithrix jacchus) that can be used to detect pharmacologically or provocation-induced AHR (airway hyper-responsiveness). Therefore a custom-made lung-function device that allows application of defined aerosol doses during measurement was developed. It was hypothesized that LPS (lipopolysaccharide)-challenged marmosets show AHR compared with non-challenged healthy subjects. Invasive plethysmography was performed in 12 anaesthetized orotracheally intubated and spontaneously breathing marmosets. Pulmonary data of RL (lung resistance), Cdyn (dynamic compliance), EF50 (mid-expiratory flow), Poes (oesophageal pressure), MV (minute volume), respiratory frequency (f) and VT (tidal volume) were collected. Measurements were conducted under baseline conditions and under MCh (methacholine)-induced bronchoconstriction. The measurement was repeated with the same group of animals after induction of an acute lung inflammation by intratracheal application of LPS. PDs (provocative doses) of MCh to achieve a certain increase in RL were significantly lower after LPS administration. AHR was demonstrated in the LPS treated compared with the naïve animals. The recorded lung-function data provide ground for pre-clinical efficacy and safety testing of anti-inflammatory substances in the common marmoset, a new translational NHP (non-human primate) model for LPS-induced lung inflammation. CLINICAL PERSPECTIVES The established invasive lung-function testing in orotracheally intubated marmosets provides ground for pre-clinical safety and efficacy testing of pharmaceuticals in this species. Readout parameters that were previously only accessible in the classic rodent model are now established for a new NHP model. There is growing demand of marmosets as the non-rodent 'second' species in pre-clinical tests. The technique described to measure lung function in an NHP model will help to support the current need for models with a high predictive power for human clinical trials. It furthermore incorporates the 3-Rs. Marmosets are handled similar to human probands and can potentially be used for multiple studies, which reduce the animal numbers. |
Databáze: | OpenAIRE |
Externí odkaz: |